Asuragen Launches SMN1/2 Plus Kit
Products are for professional/laboratory use only. Abacus dx is pleased to announce the launch of the latest assay from the Asuragen spinal muscular atrophy (SMA) portfolio – AmplideX® PCR/CE SMN1/2 Plus Kit*.
Products are for professional/laboratory use only. Abacus dx is pleased to announce the launch of the latest assay from the Asuragen spinal muscular atrophy (SMA) portfolio – AmplideX® PCR/CE SMN1/2 Plus Kit*.
Abacus dx would like to update you with the latest products from Asuragen.
Webinar Invitation:
Looking Beyond Copy Number:
Broad SMN1 and SMN2 profiling in under four hours with the AmplideX® PCR/CE SMN1/2 Plus Kit (RUO)
Abacus dx would like to update you with the latest product from Asuragen.
The AmplideX® suite of products is designed to solve unmet testing needs in inherited genetic disorders. The technology overcame a 20-year challenge by reliably amplifying the FMR1 gene. This allowed researchers to gain a deeper understanding of fragile X syndrome, the most common known inherited cause of intellectual disability and autism.
The AmplideX® C9orf72 Kit is a tool for the reliable amplification of the hexanucleotide CG repeat in the C9orf72 gene associated with amyotrophic lateral sclerosis and frontotemporal dementia.
Abacus dx would like to update you with the latest products from Asuragen.